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ABSTRACT  37 
Streptococcus pneumoniae is an opportunistic pathogen that colonizes the nasopharynx. Herein we 38 
show that carbon availability is distinct between the nasopharynx and bloodstream of adult humans: 39 
glucose being absent in the nasopharynx whereas galactose being abundant. We demonstrate that 40 
pneumococcal neuraminidase A (NanA), which cleaves terminal sialic acid residues from host 41 
glycoproteins, exposed galactose on the surface of septal epithelial cells thereby increasing its 42 
availability during colonization. We observed that mutants of S. pneumoniae deficient in NanA and β-43 
galactosidase A (BgaA) failed to form biofilms in vivo despite normal biofilm-forming abilities in vitro. 44 
Subsequently, we observed that glucose, sucrose, and fructose were inhibitory for biofilm formation, 45 
whereas galactose, lactose and low concentrations of sialic acid were permissive. Together these 46 
findings suggested that the genes involved in biofilm formation were under some form of carbon 47 
catabolite repression (CCR), a regulatory network during which genes involved in the uptake and 48 
metabolism of less-preferred sugars are silenced during growth with preferred sugars. Supporting this 49 
notion, we observed that a mutant deficient in pyruvate oxidase, which converts pyruvate to acetyl-50 
phosphate during non-CCR inducing growth conditions, was unable to form biofilms. Subsequent 51 
comparative RNA-seq analyses of planktonic- and biofilm-grown pneumococci showed that metabolic 52 
pathways involving the conversion of pyruvate to acetyl-phosphate and subsequently leading to fatty 53 
acid biosynthesis were consistently up-regulated during diverse biofilm growth conditions. We 54 
conclude carbon availability in the nasopharynx impacts pneumococcal biofilm formation in vivo. 55 
Additionally, biofilm formation involves metabolic pathways not previously appreciated to play an 56 
important role.   57 
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INTRODUCTION 58 
Streptococcus pneumoniae (the pneumococcus) is a Gram-positive bacterium that can 59 
colonize the human nasopharynx. It is also an opportunistic pathogen capable of causing a wide-60 
spectrum of diseases including sinusitis, otitis media, pneumonia, bacteremia, and meningitis (1). The 61 
greatest burden of pneumococcal disease is borne by infants, the elderly, and individuals who are 62 
immunocompromised (2, 3). Colonization of healthy individuals with the pneumococcus can last 63 
several months and is typically asymptomatic (1, 4, 5). It has been estimated that 25-40% of children 64 
in daycare and 10-15% of adults with children are carriers of S. pneumoniae (6). Due to these high 65 
carriage rates, over 14.5 million episodes of invasive pneumococcal disease (IPD) are recorded 66 
annually in children worldwide (7, 8). Likewise, the pneumococcus is the leading cause of infectious 67 
death in the elderly, with a case-fatality rate of 10-25% (3, 9, 10). Since colonization is the first step in 68 
pneumococcal pathogenesis, understanding the underlying molecular mechanisms can potentially 69 
allow for design and development of new vaccines or drugs to prevent opportunistic infections in 70 
vulnerable individuals.  71 
Biofilms are surface attached communities of bacteria encased within an extracellular matrix 72 
(11, 12). Pneumococcal biofilms have been detected on nasal septa biopsies from humans with 73 
sinusitis, on septal epithelia of experimentally challenged mice, and form in vitro on cultured 74 
respiratory epithelial cells and abiotic surfaces covered with bacterial media (13-17). Biofilm formation 75 
during colonization is thought to confer protection against host defenses and desiccation (18, 19). 76 
Dislodged pneumococcal aggregates in mucus may also act as vehicles for transmission on fomites 77 
(20). Of note, nutrient availability within the nasopharynx is thought to be poor, with carbohydrates 78 
and other essential metabolites limited in quantity or sequestered by the host (21). Along such lines, 79 
in vitro biofilm formation has been reported to be optimal during growth in nutrient poor conditions 80 
(22), suggesting there may be a link between these occurrences.  81 
The importance of carbohydrate acquisition for S. pneumoniae is evidenced by the fact that a 82 
large portion of its genome is devoted to carbohydrate uptake and processing (23). Similar to many 83 
other bacteria, the pneumococcus selectively metabolizes certain sugars first, such as glucose. When 84 
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present, the pneumococcus modifies gene expression to ensure the prioritized usage of these sugars 85 
through a process called carbon catabolite repression (CCR). Pertinent to this manuscript, glucose-86 
mediated CCR results in the conversion of pyruvate to lactate, using the enzyme lactate 87 
dehydrogenase (24). Whereas in the absence of glucose and growth in galactose, pyruvate is 88 
converted to acetyl phosphate using the enzyme pyruvate oxidase (Fig 1A) (25). Pyruvate oxidase is 89 
a key enzyme in the non-lactic acid producing metabolic pathway in S. pneumoniae and its 90 
homologues are under catabolite repression in a number of bacterial species. Encoded by spxB, 91 
pyruvate oxidase-dependent metabolism results in the conversion of pyruvate to acetyl-phosphate 92 
that is a precursor for fatty acid biosynthesis and amino acids such as leucine (26, 27). During this 93 
process hydrogen peroxide is generated, which has been shown to be a virulence determinant (28). 94 
Of note, we have previously documented a stark requirement for SpxB during in vivo biofilm formation 95 
(29); at the time this was attributed to hydrogen peroxide mediated bacterial autolysis which was 96 
proposed to promote formation of extracellular matrix.  97 
Numerous other pneumococcal genes have been shown to be required for successful 98 
colonization. This includes the gene encoding the dominant pneumococcal neuraminidase NanA that 99 
cleaves terminal sialic acid residues off host glycoproteins (Fig 1B) (30-32). NanA has been proposed 100 
to promote colonization by multiple means: 1) NanA frees sialic acid which then serves as carbon 101 
source for pneumococci in the nasopharynx (33); 2) NanA exposes galactose and N-102 
acetylglucosamine residues normally shielded by sialic acid for bacterial adhesion (34); 3) NanA 103 
allows the pneumococcus to escape entrapment within the heavily glycosylated mucus (35, 36); 4) 104 
NanA cleaves glyconjugates off of host immune effector proteins altering their function (37). Of note, a 105 
nanA deficient mutant of S. pneumoniae was reported to have decreased biofilm formation during 106 
growth on cultured epithelial cells in vitro (30).  107 
Herein, we examined the requirement for galactose, the predominant sugar found in the 108 
nasopharynx, for biofilm formation during colonization and the role of neuraminidase A in its exposure 109 
on the cell surface. We also use RNA-seq to characterize the S. pneumoniae transcriptome during 110 
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planktonic and biofilm growth under distinct carbon sources. Our findings suggest that anatomical-site 111 
specific carbon availability impacts the growth phenotype of S. pneumoniae in vivo.  112 
 113 
 114 
MATERIALS AND METHODS 115 
Human samples. Nasal lavage fluid (NALF) and serum was collected from human volunteers 116 
experimentally colonized with S. pneumoniae serotype 6B strain BHN418 as part of independent 117 
studies (38, 39). Briefly, healthy adult volunteers, aged 18-60 were inoculated with pneumococcus as 118 
previously described (40). Samples were collected at day 21 following inoculation and frozen, with 119 
designations made as to whether individuals were colonized or not based on successful culture of S. 120 
pneumoniae from nasal lavage fluid (NALF). Samples were provided in a de-identified fashion and 121 
deemed by the Institutional Review Board at The University of Texas Health Science Center at San 122 
Antonio (UTHSCSA) as not meeting the criteria for human subject research.   123 
 124 
Mice. Female BALB/c mice 6-weeks of age were obtained from The Jackson Laboratory (Bar Harbor, 125 
ME). All animal experiments were performed with protocols reviewed and approved by the Institutional 126 
Animal Care and Use Committees at UTHSCSA (protocol # 13032-34-01C). Animal care and 127 
experimental protocols adhered to Public Law 89-544 (Animal Welfare Act) and its amendments, 128 
Public Health Services guidelines, and the Guide for the care and use of Laboratory Animas (U.S. 129 
Department of Health & Human Services). 130 
 131 
Bacteria. Mouse colonization studies were performed using serotype 6A strain 6A-10, or isogenic 132 
mutants deficient in neuraminidase A (i.e. 6A-10 ΔnanA), β-galactosidase BgaA (i.e. 6A-10 ΔbgaA), or 133 
pyruvate oxidase (i.e. 6A-10 ΔspxB). 6A-10 has previously been shown to form robust biofilms in vivo 134 
(29). Laboratory strains D39 and TIGR4, along with a TIGR4 mutant deficient in SpxB (i.e. T4 ΔspxB), 135 
were used for the testing of biofilm formation in vitro (23, 41). Isogenic deletion mutants were created 136 
by allelic exchange using mutagenic PCR constructs consisting of fragments of the flanking genes 137 
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around an erythromycin resistance cassette (42). Unless noted otherwise, S. pneumoniae were grown 138 
in Todd Hewitt broth (THB) at 37°C in 5% CO2. Mutants were kept under antibiotic selection with 1 139 
µg/ml erythromycin at all times with exception to outgrowth for experiments. In these instances 140 
antibiotics were removed to avoid confounding effects of the antimicrobial on autolysis (43), which is 141 
known to affect biofilm formation (22). 142 
 143 
Measurement of carbohydrate levels in human nasal lavage fluid and serum. The concentration 144 
of free glucose, galactose, and sialic acid were measured using fluorescent carbohydrate detection 145 
kits from BioVision (Milpitas, CA). 146 
 147 
Staining of septal epithelium to visualize exposed galactose. Female 6-week-old BALB/c mice 148 
were inoculated with 105 colony-forming units of 6A-10 in 10µl saline as previously described (29). 149 
Septa were collected 7 days post-inoculation (dpi) without removal from the nasal cavity (44). 150 
Samples were placed in 10% neutral buffered formalin overnight, then transferred to 15% EDTA for 151 
decalcification for 4 weeks, with weekly changes of EDTA. Following decalcification, samples were 152 
frozen in optimal cutting temperature compound and cryo-sectioned. Slides were stained with FITC-153 
labeled Erythrina cristagalli lectin (Vector Laboratories, Burlingame, CA) for 30 minutes at room 154 
temperature. Following routine staining with DAPI, slides were visualized using a Prairie Ultima 2-155 
photon confocal microscope system (Bruker, Middleton, WI).  156 
 157 
Visualization of in vivo biofilms using scanning electron microscopy (SEM). Nasal septa from 158 
colonized mice were collected as described above, with exception that mice were exsanguinated and 159 
then perfused with saline following euthanasia to prevent the accumulation of erythrocytes during 160 
dissection procedures. Nasal septa were prepared for SEM as described previously (29). 161 
 162 
In vitro biofilm formation. Biofilms were grown with THB in 6-well polystyrene plates (COSTAR) 163 
(29). Media was changed after 24 hr and biofilm biomass was measured after 48 hr. To determine 164 
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biofilm biomass wells were stained with 1% crystal violet for 10 minutes. Following three rinses with 165 
saline, biofilm-attached crystal violet stain was solubilized using 95% ethanol and the optical density 166 
at 540 nm read using a HybridH4 plate reader (BioTek, Winooski, VT). For experiments using sugar-167 
supplemented media, the designated sugar was added in increasing concentration to 50% THB prior 168 
to its use and filter sterilized. In other instances acetate and lactate at designated concentrations were 169 
added to media and the pH of the media adjusted to 7.4 before experimental use.  170 
 171 
Adhesion assay. Detroit-562 nasopharyngeal epithelial cells were grown to confluency in 24-well 172 
plates in F12 media supplemented with 10% fetal bovine serum. Tumor necrosis factor-α was added 173 
to each well to a final concentration of 10 ng/mL and plates incubated at 37°C for two hours. Cells 174 
were washed and 1 ml of F12 media containing 106 CFU of S. pneumoniae was added and incubated 175 
for 1 hr at 37°C. Cells were washed with sterile saline three times, scraped in 100 µl water, and 176 
lysates plated to determine the number of adherent pneumococci.  Experiments were performed in 177 
four biological replicates with three technical replicates each time. 178 
 179 
Isolation of RNA. S. pneumoniae was grown planktonically or in polystyrene 6-well plates as 2-day-180 
old biofilms in 50% THB supplemented with the designated sugar at 1%. Planktonic pneumococci 181 
were pelleted by centrifugation, washed with saline, treated with RNAprotect (Qiagen), and stored at -182 
80°C. Pneumococci in biofilms were rinsed with saline, scraped off the plastic surface, pelleted, 183 
treated with RNAprotect, and stored at -80°C. Samples for each of the 5 growth conditions were 184 
collected in triplicate (15 samples total). Total RNA was extracted from each replicate separately 185 
using enzymatic lysis of pneumococcal cells (10 µL mutanolysin, 20 µL proteinase K, 15 µL lysozyme, 186 
and 55 µL TE) followed by RNA extraction with the RNeasy Micro Kit (Qiagen) with DNase treatment 187 
on column and in solution. Samples were then depleted of rRNAs using the Ribo-Zero rRNA Removal 188 
Kit for Gram-positive bacteria (Illumina, San Diego, CA).  189 
 190 
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RNA-seq. Illumina strand-specific RNA-seq libraries were constructed with the TruSeq RNA Sample 191 
Prep kit (Illumina, San Diego, CA) per manufacturer’s protocol. Between 1st and 2nd-strand cDNA 192 
synthesis, the primers and nucleotides were removed from the samples with NucAway spin columns 193 
(Ambion, Austin, TX). The 2nd strand was synthesized with a dNTP mix containing dUTP. Adapters 194 
containing 6 nucleotide indexes were ligated to the double-stranded cDNA. After adapter ligation, the 195 
2nd strand cDNA was digested with 2 units of Uracil-N-Glycosylase (Applied Biosystems, Carlsbad, 196 
CA). Size selection of the library performed with AMPure XT beads (Beckman Coulter Genomics, 197 
Danvers, MA). All 15 libraries were multiplexed on one flowcell lane of a 150nt paired-end run of the 198 
Illumina HiSeq4000 sequencing platform. Deposition of the RNA-seq reads to the Gene Expression 199 
Omnibus (GEO) database is in progress. 200 
 201 
Transcriptomic analyses. Reads from each of the 15 samples were mapped onto the newly 202 
sequenced S. pneumoniae 6A-10 genome using Bowtie version 0.12.9 (45). The 6A-10 genome was 203 
sequenced using the Pacific Biosciences RS-II platform and assembled into a single contig. The 204 
alignment BAM files from Bowtie were used to compute gene expression levels and test each gene 205 
for differential expression. The number of reads that mapped to each 6A-10 gene was calculated 206 
using the python package HTSeq version 0.4.7 (46). The read count represents the expression of the 207 
gene. Differential gene expression analysis was conducted using the DESeq R package version 208 
1.5.24 (available from Bioconductor (47)). The DESeq analysis resulted in the determination of 209 
potential differentially expressed genes when compared between the control planktonic samples and 210 
the biofilm samples. The read counts for each sample were normalized for sequencing depth and 211 
distortion caused by highly differentially expressed genes. Then the negative binomial model was 212 
used to test the significance of differential expression between two conditions. The differentially 213 
expressed genes were deemed significant if the False Discovery Rate was less than 0.05, the gene 214 
expression was above the 10th percentile and showed greater than 2-fold change difference (up-215 
regulated or down-regulated) between the conditions. Finally, because no metabolic pathway 216 
information exists in the public domain for the newly sequenced 6A-10 genome, TIGR4 orthologs of 217 
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6A-10 differentially regulated genes were subjected to a pathway enrichment analysis with GAGE 218 
version 2.18.0 (48) and KEGG orthology terms and pathway maps for S. pneumoniae TIGR4 (49). 219 
The pathway analysis output was filtered to include only non-redundant pathways at P<0.05. Heat 220 
maps were generated with the R package gplots version 2.17.0. Differentially regulated genes 221 
involved in pyruvate metabolism in S. pneumoniae were painted on the KEGG pyruvate metabolism 222 
reference pathway (SPN00620) using the packages GAGE and pathview (48, 50). 223 
 224 
Statistical analyses. Statistical analyses of non-in silico data were performed using Prism 5.0 225 
(GraphPad Software: La Jolla, CA). All non-parametric data sets were analyzed using a Mann-226 
Whitney test while parametric data sets were analyzed using Student’s t-test. One-Way ANOVA was 227 
used for multiple group analyses. P-values less than 0.05 were deemed significant. 228 
 229 
 230 
RESULTS 231 
Glucose, sialic acid, and galactose levels vary in an anatomical site-specific manner. We first 232 
sought to determine the abundance of CCR-inducing glucose and the less preferred carbohydrates 233 
sialic acid and galactose at two anatomical sites important for pneumococcal infection: the 234 
nasopharynx and within the blood. To do this we tested paired NALF and serum samples taken from 235 
experimentally colonized human adult volunteers 21 days after inoculation with S. pneumoniae strain 236 
BHN418, a serotype 6B isolate (38, 39). Paired samples from carriage negative individuals were also 237 
tested for control. Glucose was by far the most abundant sugar present within serum (90.23 ± 11.33 238 
nmol/mL), with sialic acid present at modest concentrations (60.66 ± 3.31 nmol/mL), and galactose at 239 
low levels (10.76 ± 0.46 nmol/mL). In contrast, glucose was undetectable, sialic acid levels were 240 
significantly lower (20.88 ± 1.01 nmol/mL), and galactose emerged as the most abundant sugar 241 
(37.09 ± 0.89 nmol/mL) in NALF samples (Fig 2A). Significant differences in the levels of all three 242 
carbohydrates were observed between NALF and serum samples. Yet only galactose levels were 243 
significantly different between NALF from carriage positive individuals versus carriage negative 244 
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controls (carriage positive: 39.39 ± 0.646 nmol/mL; carriage negative: 34.80 ± 1.12 nmol/mL; 245 
P=0.0087). This modest increase in NALF galactose levels suggested colonizing pneumococci 246 
perhaps liberated this sugar. As such, we examined nasal septa taken from colonized and 247 
uncolonized mice 7 days post-inoculation (dpi) with strain 6A-10, a serotype 6A nasopharyngeal 248 
isolate of S. pneumoniae (Fig 2B) (29). Mice carrying 6A-10 exhibited a high degree of exposed 249 
galactose on septal epithelial cells as determined by fluorescent staining with a FITC-labeled lectin 250 
specific for this sugar. Lectin staining was not evident in septa from uninfected controls and was 251 
strongly diminished in septa from mice experimentally colonized with 6A-10 ΔnanA, an isogenic 252 
mutant deficient in NanA. Thus, exposure of galactose on epithelial cells required neuraminidase 253 
activity by the colonizing strain. 254 
 255 
Neuraminidase A and β-galactosidase A activity are required for biofilm formation within the 256 
nasopharynx. We have previously reported that biofilms form within the nasopharynx of S. 257 
pneumoniae colonized mice (29). Consistent with this report, we observed 6A-10 biofilms formed on 258 
nasal septa epithelial cells of mice at 7 dpi using SEM (Fig 3). In stark contrast, septa from mice 259 
colonized with 6A-10 ΔnanA appeared identical to PBS treated animals with the exception to the 260 
presence of leukocytes. In a similar fashion, mice inoculated with 6A-10 ΔbgaA, an isogenic mutant 261 
deficient in β-galactosidase BgaA, also failed to develop bacterial biofilms on nasal septa epithelial 262 
cells at 7dpi (Fig 3). Briefly, BgaA is capable of cleaving β1-4 linked galactose that underlies terminal 263 
sialic acid on host glyconjugates (Fig 1B). Importantly, the number of pneumococci present in NALF 264 
as measured by colony counts was not significantly different between 6A-10, 6A-10 ΔnanA, or 6A-10 265 
ΔbgaA colonized mice at 7 and 14 dpi; albeit there was a trend towards reduced 6A-10 ΔbgaA levels 266 
on day 7 in NALF (Fig S1). These results show that NanA and BgaA impact the growth phenotype of 267 
the pneumococcus during asymptomatic colonization, although have no obvious impact on isolated 268 
NALF bacterial counts. 269 
 270 
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Neuraminidase A and β-galactosidase A are not required for in vitro biofilm formation and 271 
have differential contribution to adhesion. One possible explanation for the lack of S. pneumoniae 272 
biofilms formed on the septa of 6A-10 ΔnanA and 6A-10 ΔbgaA colonized mice was that these 273 
encoded enzymes modulate the interactions between individual pneumococci. Suggesting otherwise, 274 
we observed no differences between 6A-10, 6A-10 ΔnanA, or 6A-10 ΔbgaA during in vitro biofilm 275 
formation on polystyrene plates (Fig 4A). Alternatively, these enzymes may promote bacterial 276 
adhesion to epithelial cells, a key first step for biofilm formation. Herein, we observed no significant 277 
attenuation in the adhesion of encapsulated 6A-10 ΔnanA to Detroit 562 epithelial cells in vitro (Fig 278 
4B). However, we did observe that 6A-10 ΔbgaA was less adhesive than its wild type parent strain. 279 
Thus, the attenuation of 6A-10 ΔbgaA, but not 6A-10 ΔnanA, in regards to in vivo S. pneumoniae 280 
biofilm formation may be due to decreased adhesion to host cells.  281 
 282 
Non-CCR acting carbohydrates are permissive for biofilm formation. We subsequently tested if 283 
reliance on specific carbohydrates impacted the ability of S. pneumoniae to form biofilms in vitro. To 284 
do this we used 50%THB media that contained 0.1% glucose as base media.  We used 50% THB 285 
because it permitted detection of positive and negative changes in biofilm biomass during growth of 286 
pneumococci in vitro with different carbon sources (Fig S2A). Moreover, because once media was 287 
supplemented with other carbohydrates, with exception to high levels of sialic acid, no detrimental 288 
affect on growth was detected (Fig S2B,C). Supplementation of 50% THB media with CCR-inducing 289 
glucose, sucrose, and fructose were inhibitory to biofilm formation in vitro. In contrast, the less 290 
preferred sugars galactose and lactose were permissive for in vitro biofilm formation (Fig 5A). Sialic 291 
acid was permissive for biofilm formation but only at low concentrations (Fig 5A). Higher 292 
concentrations (>0.125%) of sialic acid were toxic to 6A-10 (Fig S2B) precluding its study. 293 
Importantly, the inhibitory effects of glucose on in vitro biofilm formation were also observed in 294 
laboratory strains TIGR4 and D39 (Fig S3). We also observed that deletion of spxB, which is 295 
repressed during glucose-induced CCR, in a 6A-10 and TIGR4 backgrounds resulted in mutants 296 
unable to form biofilms in vitro (Fig 5B). What is more, addition of acetate to the culture medium 297 
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increased the biomass of 6A-10 biofilms. In contrast, addition of lactate caused a downward trend in 298 
6A-10 biofilm biomass (Fig 5C). We conclude that biofilm formation is tied to non-lactic acid 299 
producing, i.e. less preferred carbohydrate driven metabolism. 300 
 301 
Metabolic pathways differentially regulated during biofilm formation. To elucidate other 302 
metabolic pathways that might be involved in biofilm formation we performed RNA-seq using RNA 303 
isolated from 6A-10 grown planktonically and as a biofilm in 50% THB and in 50% THB supplemented 304 
with 1% galactose. We also performed RNA-seq on 6A-10 RNA isolated from pneumococci grown 305 
planktonically in 50% THB supplemented with 1% glucose. 6A-10 does not form biofilms in media 306 
supplemented with glucose (Fig 5A), as such this growth condition was not included in these 307 
analyses. TIGR4 orthologs of 6A-10 genes determined to be differentially expressed in biofilm vs. 308 
planktonic growth across the different conditions by DESeq analysis of RNA-seq data were subjected 309 
to a pathway enrichment analysis performed with GAGE, KEGG orthology terms, and pathway maps 310 
for S. pneumoniae TIGR4 (Fig 6A). We observed that the genes involved in pyruvate metabolism 311 
(KEGG pathway spn00620) were up-regulated across all our comparisons (Fig 6A). In addition, 312 
genes involved in fatty acid biosynthesis (KEGG pathway spn00061) and fatty acid metabolism 313 
(KEGG pathway spn01212) were also consistently up-regulated. Genes involved in pyrimidine 314 
metabolism (KEGG pathway spn00240) were only up-regulated when comparisons were made 315 
against planktonic pneumococci grown in THB supplemented with a sugar. Likewise, genes involved 316 
in ribosome expression (KEGG pathway spn03010) were exclusively up-regulated in all instances 317 
when biofilm pneumococci were grown in unsupplemented media. These latter two pathways may be 318 
regulated as a result of metabolite-specific phenomena. Genes involved in oxidative phosphorylation 319 
(KEGG pathway Spn00190) were down-regulated but this too was only observed when comparisons 320 
were made with biofilm pneumococci grown in supplemented media. It is of note that the pyruvate 321 
metabolism pathway ties directly into fatty acid synthesis and fatty acid metabolism pathway (Fig 6B). 322 
As such, these analyses suggest that fatty acid biosynthesis is an important aspect of pneumococcal 323 
biofilm formation that was up to this point unappreciated. 324 
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Of note, bgaA expression was modestly increased under all growth conditions when media 325 
was supplemented with galactose versus unsupplemented media. It was also increased in galactose 326 
planktonic versus glucose planktonic cultures. No such differences were observed for nanA. In 327 
contrast, nanA expression was reduced during biofilm growth in galactose versus unsupplemented 328 
50% THB (Fig S4).  329 
 330 
DISCUSSION 331 
 Carbon acquisition is critical for S. pneumoniae survival. For this reason, a major part of the 332 
pneumococcus genome is dedicated towards the uptake and processing of carbohydrates including 333 
sialic acid, galactose, and glucose (23, 51). Since the initial discovery that the pneumococcus 334 
produces neuraminidase, much effort has gone towards elucidating its role in the disease process 335 
(30, 52-55), determining the impact of free sialic acid on the bacterium’s metabolism (31, 33, 56, 57), 336 
and testing whether inhibition of neuraminidase activity is protective (58). Along such lines, Marion et 337 
al. determined that S. pneumoniae was capable of growth with sialic acid as the sole carbon source 338 
(33). Similar to our findings, it was reported that growth was slower and the cultures failed to reach the 339 
same optical density observed when glucose was used instead as the sole carbon source. 340 
Subsequently, Trappetti et al. showed that exogenous sialic acid enhanced biofilm formation in vitro 341 
(31). Herein, we build on these observations and suggest that one primary role for pneumococcal 342 
NanA is to facilitate exposure of underlying galactose residues, and that the predominance of this 343 
less-preferred carbon within the nasopharynx, along with the absence of glucose, promotes growth of 344 
S. pneumoniae in a biofilm.  345 
 There have been multiple reports that examined a role for NanA and BgaA in adhesion to 346 
epithelial cells. Tong et al. showed that serotype 2 strain D39 deficient in NanA was attenuated for 347 
adherence to chinchilla tracheal epithelium and colonization in vivo (34, 59). Brittan et al. also 348 
reported that a D39 NanA deficient mutant was attenuated for its ability to adhere to the pharyngeal, 349 
laryngeal and lung epithelial cells (60). However, King et al. reported no differences in adhesion of 350 
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D39 ΔnanA to Detroit 562 human upper airway epithelial cell lines (36). These discrepancies might be 351 
attributed to differences in experimental procedures used and intrinsic variability in the D39 stocks 352 
that were tested. Nonetheless, King et al. showed that an unencapsulated derivative of D39 lacking 353 
either NanA or BgaA (i.e. R6 ΔnanA, R6 ΔbgaA) had reduced adhesive abilities in comparison to wild 354 
type R6. A finding that suggested a more obvious role for these proteins in adhesion when in an 355 
unencapsulated setting (36). In a later study, Limoli et al. showed that the role of BgaA in promoting 356 
adhesion extended to D39 and C06_18, a serotype 22F strain, but not another two strains belonging 357 
to other serotypes (61). Of note, surface accessibility of pneumococcal adhesins has since been 358 
shown to depend on capsule type; with differences reported across isogenic capsule-switch mutants 359 
having the same genome (62). Thus, the different capsule types of the strains tested are a plausible 360 
explanation for the differences observed by Limoli et al. (61). 361 
 Our SEM data makes it clearly evident that pneumococcal neuraminidase A and β-galactosidase 362 
BgaA activities were essential for the formation of 6A-10 biofilm aggregates on nasal septa of infected 363 
mice. This was despite no discernible effect of deleting these genes on biofilm formation in vitro. For 364 
this reason the role of NanA and BgaA in the formation of biofilms in vivo most likely involves a host 365 
component, which we propose is cell surface galactose that underlies sialic acid. In support of this, we 366 
demonstrate that the presence of NanA dramatically increased the exposure of non CCR-acting 367 
galactose on the surface of septal epithelial cells in vivo. Moreover, that spxB, whose expression is 368 
suppressed by glucose-mediated CCR and derepressed under growth in galactose (26, 27), was 369 
essential for biofilm formation in vitro and in vivo. The latter in vivo result recently published by our 370 
group (29). Consistent with this notion, we detected galactose and not glucose in NALF samples 371 
obtained from colonized individuals. Thus, the pneumococcus operates in the absence of glucose-372 
mediated CCR during asymptomatic colonization; and growth under less-preferred alternate carbon 373 
sources, such as galactose, is permissive for biofilm growth. Of note, the discrepancy between the in 374 
vitro and in vivo requirement for NanA and BgaA in biofilm formation highlights the necessity of animal 375 
testing to discern the full contribution of suspected virulence determinants. 376 
 377 
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 It is of note that the absence of NanA or BgaA in colonizing 6A-10 did not have a negative impact 378 
on S. pneumoniae titers recovered from NALF. One caveat to this is that we did not examine septal 379 
homogenates for bacterial burden (i.e. intimately attached pneumococci were not counted); this was 380 
because our approach was longitudinal in the same set of mice. Thus, it is possible that overall 381 
burdens were different. Nonetheless, the sustained presence of pneumococci in NALF indicates that 382 
biofilm formation is not requisite for survival within the nasopharynx and that planktonic pneumococci 383 
are able to evade host clearance. This also implies that biofilm aggregates may play a different role, 384 
perhaps resistance to desiccation during transmission on fomites (63). It also suggests that the 385 
pneumococcus is able to obtain sufficient nutrients despite the absence of these enzymes. Even so, 386 
the observation that biofilms form in the nasopharynx and that biofilm formation is impaired by glucose 387 
and other CCR inducing sugars suggests that biofilms are in some manner beneficial to the bacterium 388 
and that carbon availability is a key environmental factor underlying biofilm formation. 389 
 Over the past several years, we and other investigators have explored the role of pneumococcal 390 
biofilms in the nasopharynx as a mechanism for persistence and transmission. The most unexpected 391 
finding has been that pneumococci within biofilms are less virulent than their planktonic counterparts. 392 
As evidence for this, we and others have shown that biofilm pneumococci have reduced production of 393 
capsular polysaccharide and pneumolysin, are hyper-adhesive yet have an inability to invade 394 
epithelial cells, and elicit a muted inflammatory response from host cells (29, 64, 65). Most recently 395 
Marks et al. demonstrated that inflammatory host signals, including the addition of glucose, resulted in 396 
the dispersal of S. pneumoniae biofilms. Furthermore, these biofilm-dispersed pneumococci were 397 
hyper-virulent (64). Therefore the absence of glucose in the nasopharynx of colonized adults may 398 
help to explain why colonization does not typically result in an overt inflammatory state. Additionally, 399 
increases in glucose concentration within the nasopharynx, for example as result of virus induced 400 
inflammation or even uncontrolled diabetes, may further explain why individuals with these conditions 401 
are vulnerable to IPD (64, 66, 67). Thus, catabolite repression is possibly a key event in initiating a 402 
pathogenic program of S. pneumoniae. In support of this notion, a functional CcpA has been 403 
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determined to be necessary for S. pneumoniae virulence (68). Likewise, CCR has been shown to 404 
suppress in vitro biofilm formation in E. coli and Bacillus subtilis as well (69, 70).  405 
 Along such lines, we determined that a mutant lacking pyruvate oxidase, a critical enzyme in the 406 
non-lactic acid fermentation process, was dramatically inhibited for biofilm formation in vitro and that 407 
biofilm formation could be boosted by the addition of acetate.  As indicated, we had previously shown 408 
that an spxB deficient mutant did not form biofilms in vivo (29). At the time we attributed this 409 
phenotype to impaired autolysis, which has been shown to promote the release of extracellular DNA, 410 
due to less H202 production. We now suggest that spxB deficient pneumococci also fail to form 411 
biofilms because they are fundamentally altered in a critical metabolic pathway that feeds into the 412 
production of biofilm-required products. Based on our RNA-seq analysis, we now suspect that these 413 
biofilm products may include those involved in fatty acid biosynthesis. 414 
 A role for fatty acid synthesis and metabolism in S. pneumoniae biofilm formation would not be 415 
unprecedented. Spo0A, a transcriptional regulator of spore-formation in B. subtilis, has also been 416 
identified as a regulator of de novo fatty acid synthesis and found to be required for biofilm formation. 417 
The inability of an Spo0A deficient mutant to form biofilms in vitro was restored by exogenous fatty 418 
acid supplementation (71). Likewise, fatty acid kinase A has been shown to be an important 419 
determinant of biofilm formation in Staphylococcus aureus strain USA300 (72). A recent comparative 420 
proteomic study of biofilm and planktonic Lactococcus plantarum found that fatty acid metabolism 421 
genes were among those with greatest differential levels during biofilm growth (73). Thus, 422 
considerable evidence points to an important role for fatty acids during biofilm growth, although it is 423 
unclear how fatty acids might specifically contribute to the pneumococcal biofilm phenotype. One 424 
obvious possibility is that fatty acids may be part of the extracellular matrix. This is known to be the 425 
case for Candida albicans and mycobacterial biofilms (74, 75). Alternatively changes in lipid content at 426 
the membrane level may facilitate survival in the biofilm, which for the pneumococcus has been 427 
postulated to be a stressful environment as evidenced by the up-regulation of heat shock proteins 428 
(65). Along such lines, it is worth noting that the gene with the highest level of differential expression 429 
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in biofilms grown in galactose in our RNA-seq studies was ClpL (SP_0338), a protease and member 430 
of the heat shock protein family that is stress-regulated (76). 431 
 Taken together, our results indicate that carbon availability varies in an anatomical site-specific 432 
manner in humans and this impacts in vivo biofilm formation by S. pneumoniae. Moreover, we show 433 
that neuraminidase A and β-galactosidase BgaA contribute to in vivo biofilm formation through the 434 
exposure of galactose, a non-CCR inducing carbon, which ties into biofilm formation through 435 
pyruvate- and acetyl-coA-metabolism. While the specific downstream role that fatty acid biosynthesis 436 
plays during S. pneumoniae biofilm formation remain unclear, the RNA-seq results along with the 437 
increasing literature that is supportive, suggests that this is an important research topic moving 438 
forward.  439 
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FIGURE LEGENDS 650 
Figure 1: Pneumococcal metabolism and exoglycosidase activity. A) Differential routes of S. 651 
pneumoniae pyruvate metabolism, with active pathways in the presence and absence of glucose-652 
mediated CCR denoted with bold arrows. B) Schematic representation for the exoglycosidase activity 653 
of the dominant pneumococcal neuraminidase A (NanA) and β-galactosidase A (BgaA), that cleave 654 
terminal sialic acid residues and β-1,4 linked galactose residues off host glycoconjugates, 655 
respectively. 656 
 657 
Figure 2: Galactose is present in the nasopharynx and its exposure is increased following 658 
colonization with S. pneumoniae. A) Relative levels of sugars present in serum and NALF of 659 
patients experimentally colonized with S. pneumoniae strain BHN418 (white squares) versus carriage 660 
negative controls (black squares). Each square represents an individual clinical sample. Statistical 661 
analyses were done using Mann-Whitney Test. P value: * ≤ 0.05. B) Representative fluorescent 662 
microscopy images of sections obtained from septa of mice colonized with 6A-10, 6A-10 ΔnanA, or a 663 
mock treated control (n=3 per cohort). Labeling was performed using FITC-labeled E. cristagalli lectin 664 
to indicate the presence of exposed galactose (green) and DAPI (blue) to visualize cells. Exposed 665 
galactose present on the apical mucosal epithelial cell layer is denoted with white arrows. 666 
 667 
Figure 3: Neuraminidase A and β-galactosidase A contribute to robust biofilm formation within 668 
the nasopharynx. Representative scanning electron microscopy images (at low and high 669 
magnification) of nasal septal epithelia isolated from mice colonized with wild-type S. pneumoniae 670 
strains 6A-10, 6A-10ΔnanA, 6A-10ΔbgaA (a minimum of 5 septa were examined per cohort). Nasal 671 
septa of mice challenged with saline were used as negative controls. Septa were collected at 7dpi. 672 
 673 
Figure 4: Contribution of Neuraminidase A and β-galactosidase A to biofilm formation and 674 
adhesion to host cells in vitro. A) Biofilm-forming ability of strains 6A-10, 6A-10ΔnanA, and 6A-675 
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10ΔbgaA in a 48-hour 6-well polystyrene plate model. Biofilm biomass was measured using the 676 
amount of crystal violet trapped within the biofilm at 540nm. B) Adhesive abilities of strains 6A-10, 6A-677 
10ΔnanA and 6A-10ΔbgaA to Detroit 562 cells as measured by recoverable CFU following washing 678 
and plating of bacteria. Values are expressed as fold-increase in adhesion relative to wild-type strain 679 
6A-10. Statistical analysis was performed using Mann-Whitney test. P value: ** ≤ 0.01; experiments 680 
were repeated three times with mean results shown, error bars represent standard error of the mean.  681 
 682 
Figure 5: Non-CCR acting carbohydrates are permissive for biofilm formation. A) Pneumococcal 683 
biofilm formation was assessed in diluted media (50% THB) supplemented with increasing 684 
concentrations of glucose, sucrose, fructose, galactose, lactose, and sialic acid in a 48-hour 6-well 685 
polystyrene plate model. Statistical analysis was performed using One-way Anova. Statistical 686 
significance was calculated by comparing biofilm biomass of supplemented media with that of un-687 
supplemented sugar-free media. B) Biofilm biomass at 48 hours by wild type TIGR4 and 6A-10 and 688 
respective spxB mutants. Statistical analyses compared mutant to its wild-type counterpart using a 689 
Student’s t-test. C) Biofilm biomass by strain 6A-10 in the presence of different concentrations of the 690 
end metabolites, acetate (black bars) and lactate (white bars). Statistical analyses were performed by 691 
comparing the biofilms in supplemented media with those in unsupplemented media using a Student’s 692 
t-test. P value: * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001, *** ≤ 0.0001; experiments were repeated a minimum of 693 
three times, mean results are shown, error bars represent standard error of the mean. 694 
 695 
Figure 6: Metabolic activity of pneumococci during biofilm formation. A) TIGR4 orthologs of 6A-696 
10 genes determined to be differentially expressed by DESeq analysis of RNA-seq data were 697 
subjected to a pathway enrichment analysis performed with GAGE, KEGG orthology terms and 698 
pathway maps for S. pneumoniae TIGR4. Heat maps represent log2 fold change of biofilm (BF) 699 
expression over planktonic (PK) expression, each sub-panel harbors three columns corresponding to 700 
the three paired replicates for each condition (3 replicates of BF vs. PK). Values of log2 fold change 701 
are indicated for each replicate pair. Compared growth conditions include S. pneumoniae strain 6A-10 702 
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grown as biofilm in unsupplemented media (THB BF) or media supplemented with galactose (GAL 703 
BF) versus planktonic growth phenotype in unsupplemented media (THB PK) or media supplemented 704 
with glucose (GLU PK) or galactose (GAL PK). Pathways differentially regulated across multiple 705 
growth conditions are highlighted with the same background color (e.g. pyruvate metabolism in 706 
green). B) Differentially regulated genes involved in pyruvate metabolism in S. pneumoniae were 707 
painted on the KEGG pyruvate metabolism reference pathway (SPN00620) using the packages 708 
GAGE and pathview. Each gene/enzyme box is divided into three colored thirds corresponding to the 709 
three paired replicates for each condition (3 replicates of THB BF vs. THB PK). Differential expression 710 
is depicted according to the heat map provided in the upper right corner of panel B, values are log2 711 
fold change of biofilm (THB BF) expression over planktonic (THB PK) expression. 712 
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